Summary
The purpose of the study was to investigate the in vivo metabolic pathway of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine (substrate) in rats. Firstly its potential metabolites, i.e. N-dealkylation, ring scission of pyridazine and aromatic hydroxylation products, were synthesized and then the substrate was given orally (100 mg/kg) to male or female Wistar rats at a dose of 100 mg/kg to body weight. Blood samples were collected at 0, 1, 2, 4, 6 and 8 hours after administration of substrate and blood was centrifuged to obtain serum. The substrate and its potential metabolites were separated using a gradient HPLC method on a reverse phase system. This study revealed that 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine was not metabolized to the proposed metabolites and was present unchanged in the serum.
Similar content being viewed by others
References
Balkan A., Özkanli F., Ünsal O., Gören Z., Terzioglu B. (2003): Studies on some 3-oxo-5-benzylidene-6-methyl-(4H)-2-substituted pyridazines with antinociceptive and antiinflammatory activities, FAB AD J. Pharm. Sei. 28, 19–25.
Hashizume T., Mise M, Matsumoto S., Terauchi Y., Fujii T., Imaoka S., Funae Y., Kamataki T., Miyazaki H. (2001): A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine. Drug Metab. Dispos. 29(6), 798–805.
Hashizume T., Imaoka S., Mise M., Terauchi Y., Fujii T., Miyazaki H., Kamataki T., Funae Y. (2002): Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J. Pharmacol. Exp. Ther. 300(2), 298–304.
Heykants J., Pardeol L., Janssen P.A.J. (1971): On the distribution and metabolism of azaperone (R 1929) in the rat and pig. Arzneim.-Forsch. (Drug Res.) 7,982–984.
Oruç E.E., Rollas S., Kabasakal L., Uysal MK. (1999): The in vivo metabolism of 5-(4-nitrophenyl)-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats. Drug Metab. and Drug Interact., 15,127–140.
Gülerman N.N., Oruç E.E., Kartal F., Rollas S. (2000): The in vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl)methylene] hydrazide in rats. Eur. J. Drag Metab. Pharmacokinet., 25(2), 103–108.
Kaymakcioglu B.K., Rollas S., Kartal-Aricioglu F. (2003): In vivo metabolism of itN-phenyl-N’-(33-dimethylpyrazole-4-yl)thioureain rats. Eur. J. Drug Metab Pharmacokinet., 28(4), 273–278.
Yilmaz F., Ülgen M., Doĝruer D.S., Çakir B., Şahin M.F. (1999): The in vivo hepatic metabolism of l-phenyl-2-(2-benzothiazoltaone-3-yl)ethanone and their reduced derivatives. Exp. Toxic. Pathol., 51,442–445.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oruç, E.E., Ünsal, O., Balkan, A. et al. The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats. European Journal of Drug Metabolism and Pharmacokinetics 31, 21–25 (2006). https://doi.org/10.1007/BF03190638
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190638